News and Opinions
The Global Synthetic Biology Conference: San Jose, California | May 5-8, 2025
This is where the world’s top innovators, thought leaders, entrepreneurs, and investors come together to build a better world with synthetic biology. Join us in San Jose as we explore how synbio is transforming industries from healthcare, agriculture,...
The Expert Who Kept Eye Drops From Blinding You Was Fired Yesterday
By Katherine Eban - Vanity Fair - If you’ve ever used eye drops that didn’t blind you, thank Dr. Timothy J. Pohlhaus. As of yesterday, he’s gone. And if you’ve ever been injected with a sterile drug that helped heal you instead of killing you, you have relied on the...
USC Stem Cell mouse study identifies shared genes involved in hearing and vision regeneration
By Cristy Lytal - Keck School of Medicine of USC - The same genes could hold the key to regenerating cells in the ear and eye, according to a new mouse study from the USC Stem Cell laboratory of Ksenia Gnedeva, published in the Proceedings of the National Academy of...
US researchers develop new bioreactor for enhanced stem cell growth
By Ada Shaikhnag - 3D Printing Industry News - Researchers from Los Alamos National Laboratory (LANL) have developed a 3D printed perfusion bioreactor (3D-PBR) created to improve how human bone marrow-derived mesenchymal stem cells (MSCs) grow and differentiate. With...
Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers
by National Cancer Institute (NCI) - NIH trial shows new form of TIL therapy effective against colon, rectum, pancreas, and bile duct tumors. A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved...
Molecular Pathways in Bone Marrow Stem Cell Senescence
By Physician's Weekly - Researchers conducted a retrospective study to analyze miRNA-mRNA regulatory networks influencing bone marrow mesenchymal stem cell (BMSCs) senescence in age-related osteoporosis (ARO), aiming to determine molecular markers and therapeutic...
Treating spinal cord injuries with stem cells
PODCAST by Brian Culley - Beyond Biotech - Spinal cord injuries impact millions of people worldwide and, unlike many chronic injuries, they usually arrive with no forewarning, impacting the young and old alike. Brian Culley is CEO of Lineage Cell Therapeutics and his...
A new kind of stem cell is revolutionizing regenerative medicine
By Marissa Locke Rottinghaus - ASBMB Today - Regenerative medicine is rewriting the future of health care, with stem cells leading the charge as researchers report that their experimental induced pluripotent stem cell, or iPSC, therapeutics could restore vision and...
Paralysed man stands again after receiving ‘reprogrammed’ stem cells
By Smriti Mallapaty - Nature - Another man also regained some movement, but two others experienced minimal improvement. A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal-cord injury. The Japanese man was one of...
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
by BioSpace Insights - Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit. With the cell and gene therapies (CGTs) sector...
Will Stem Cell Clinics Flourish Under RFK Jr.?
by Rachael Robertson MedPageToday - After HHS Secretary Robert F. Kennedy Jr. hosted a roundtableopens in a new tab or window on reducing regulations on stem cells earlier this month, experts have raised concerns about a potential flourishing of questionable stem cell...
Cells That Build Themselves Into an Embryo? Scientists Just Made It Happen
By University of California - Santa Cruz - SciTechDaily - Scientists have found a way to study early embryonic development without real embryos. Using CRISPR, they programmed stem cells to self-organize into structures mimicking early embryos. The cells show...
Healthspan Action Coalition and Kitalys Institute Propose Landmark Legislation to Promote Healthy Longevity
“An important step towards slowing aging and the onset of major age-related chronic diseases” Washington, DC and San Francisco, CA, March 27, 2025— The Healthspan Action Coalition (HSAC) and the Kitalys Institute jointly proposed today the initial draft of a bill...
Probing the Mysteries of the Aging Brain
By Dennis Nealon - Harvard Research - Research led by new faculty member Michael Segel focuses on mammalian lifespans Sixteen years ago, Michael Segel was a rising senior at Brookline High School in Massachusetts when, acting on a friend’s suggestion, he signed on for...
Building a regenerative medicine industry: Lessons from North Carolina
By Tim Bertram - Pharmaphorum - The field of regenerative medicine is advancing rapidly, offering transformative solutions for a wide range of health conditions. However, while scientific breakthroughs in regenerative medicines like cell and gene therapies continue,...
New CRISPR tool enables more seamless gene editing — and improved disease modeling
By Bill Hathaway - Yale Health & Medicine - Yale scientists have developed a CRISPR technology that can assess genetic interactions on a host of immunological responses to multiple diseases, including cancer. Advances in the gene-editing technology known as...
New CAR-T Cell Therapy Shows Promise for Hard-to-Treat Cancers
by Laura Kelley - University of Colorado Cancer Center - Researchers at CU Anschutz Medical Campus have developed ALA-CART, a next-generation therapy aimed at improving outcomes for patients with resistant cancers. “This next-generation approach, called ALA-CART...
Scientists create universal vascular graft with stem cells to improve surgery for cardiovascular disease
by Morgridge Institute for Research - MedicalXpress - Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and regenerative...
Gene Therapy in an Implant: Neurotech Lands First FDA Approval in Rare Vision Disorder
By Frank Vinluan - MedCity News - Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder. Protein therapies...
Clinical Trial Tests Novel Stem-Cell Treatment for Parkinson’s Disease
By Mass General Brigham - A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson’s disease in which a patient’s stem cells are reprogrammed to replace dopamine...
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List


Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.